+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global At-home Drug of Abuse Testing Market by Product (Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits), Test Type (Cups, Strips), Drug, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716235
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The At-home Drug of Abuse Testing Market size was estimated at USD 2.68 billion in 2023, USD 2.88 billion in 2024, and is expected to grow at a CAGR of 7.25% to reach USD 4.38 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the At-home Drug of Abuse Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the At-home Drug of Abuse Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the At-home Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Accuquik by AdvaCare Pharma USA, Atlas Medical GmbH, BioMerieux, Inc., Biopanda Reagents Ltd., BTNX Inc., Confirm BioSciences, Drägerwerk AG & Co. KGaA, Exploro Products, Identify Diagnostics by Medical Distribution Group, Inc., Innovatek Medical Inc., InTec Products, Inc., Laboratory Corporation of America Holdings, McKesson Medical-Surgical, MyDiagnostics by Phyteos Helath Systems Inc., myLAB Box Inc., OraSure Technologies, Inc., Phamatech Inc. by Caris Life Sciences, Psychemedics Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., UCP Biosciences Inc., Vitrosens Biotechnology, and Xiamen Boson Biotech Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the At-home Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Blood-Based Testing Kits
    • Breathalyzer Testing Kits
    • Hair-Based Testing Kits
    • Saliva-Based Testing Kits
    • Urine-Based Testing Kits
  • Test Type
    • Cups
    • Strips
  • Drug
    • Alcohol
    • Amphetamines
    • Benzodiazepines
    • Cocaine
    • Marijuana
    • Opioids
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the At-home Drug of Abuse Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the At-home Drug of Abuse Testing Market?
  3. What are the technology trends and regulatory frameworks in the At-home Drug of Abuse Testing Market?
  4. What is the market share of the leading vendors in the At-home Drug of Abuse Testing Market?
  5. Which modes and strategic moves are suitable for entering the At-home Drug of Abuse Testing Market?

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. At-home Drug of Abuse Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing use and production of illicit drugs
5.1.1.2. Government initiatives to reduce drug abuse
5.1.1.3. Expansion of drug production necessitates effective test measures
5.1.2. Restraints
5.1.2.1. Inability of testing products to detect small amounts of special drugs
5.1.3. Opportunities
5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
5.1.4. Challenges
5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. At-home Drug of Abuse Testing Market, by Product
6.1. Introduction
6.2. Blood-Based Testing Kits
6.3. Breathalyzer Testing Kits
6.4. Hair-Based Testing Kits
6.5. Saliva-Based Testing Kits
6.6. Urine-Based Testing Kits
7. At-home Drug of Abuse Testing Market, by Test Type
7.1. Introduction
7.2. Cups
7.3. Strips
8. At-home Drug of Abuse Testing Market, by Drug
8.1. Introduction
8.2. Alcohol
8.3. Amphetamines
8.4. Benzodiazepines
8.5. Cocaine
8.6. Marijuana
8.7. Opioids
9. At-home Drug of Abuse Testing Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas At-home Drug of Abuse Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific At-home Drug of Abuse Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AccuBioTech Co., Ltd.
14.1.3. Accuquik by AdvaCare Pharma USA
14.1.4. Atlas Medical GmbH
14.1.5. BioMerieux, Inc.
14.1.6. Biopanda Reagents Ltd.
14.1.7. BTNX Inc.
14.1.8. Confirm BioSciences
14.1.9. Drägerwerk AG & Co. KGaA
14.1.10. Exploro Products
14.1.11. Identify Diagnostics by Medical Distribution Group, Inc.
14.1.12. Innovatek Medical Inc.
14.1.13. InTec Products, Inc.
14.1.14. Laboratory Corporation of America Holdings
14.1.15. McKesson Medical-Surgical
14.1.16. MyDiagnostics by Phyteos Helath Systems Inc.
14.1.17. myLAB Box Inc.
14.1.18. OraSure Technologies, Inc.
14.1.19. Phamatech Inc. by Caris Life Sciences
14.1.20. Psychemedics Corporation
14.1.21. Siemens Healthineers AG
14.1.22. Thermo Fisher Scientific Inc.
14.1.23. UCP Biosciences Inc.
14.1.24. Vitrosens Biotechnology
14.1.25. Xiamen Boson Biotech Co., Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
FIGURE 7. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 12. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Accuquik by AdvaCare Pharma USA
  • Atlas Medical GmbH
  • BioMerieux, Inc.
  • Biopanda Reagents Ltd.
  • BTNX Inc.
  • Confirm BioSciences
  • Drägerwerk AG & Co. KGaA
  • Exploro Products
  • Identify Diagnostics by Medical Distribution Group, Inc.
  • Innovatek Medical Inc.
  • InTec Products, Inc.
  • Laboratory Corporation of America Holdings
  • McKesson Medical-Surgical
  • MyDiagnostics by Phyteos Helath Systems Inc.
  • myLAB Box Inc.
  • OraSure Technologies, Inc.
  • Phamatech Inc. by Caris Life Sciences
  • Psychemedics Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • UCP Biosciences Inc.
  • Vitrosens Biotechnology
  • Xiamen Boson Biotech Co., Ltd.

Methodology

Loading
LOADING...

Table Information